ReviewCell transplantation
Advanced medical treatments for hair loss.
Review in Cell transplantation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Monitoring the Response to JAK Inhibitor Treatment in Alopecia Areata Using Reflectance Confocal Microscopy and Videotrichoscopy: A 60-Week Observational Study.Dermatology and therapy · 2026Article
- Stem cell-based approaches for alopecia: A narrative review of current and emerging treatment strategies.Cell transplantationReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patients with hair-loss experience stress and a loss of confidence. Several factors contribute to hair loss, including aging, androgen hormone effects, genetics, and diseases. Normally, physicians treat hair loss using medications such as minoxidil and finasteride. However, these treatments are associated with side effects and some limitations. Currently, hair transplantation is the most efficient technique; however, it requires the use of numerous hair grafts. Stem cell and hair follicle cell (HFC) treatments have been developed for hair-loss treatment. Previously, stem cell and HFC therapies have been shown to promote hair development, prolong the anagen phase, and increase hair diameter and density. In addition, growth factors and extracellular vesicles (EVs) are important for prolonging the anagen phase, improving hair follicle health, and reducing dihydrotestosterone effects. Furthermore, gene therapy and tissue engineering have also been developed as treatments for hair loss. In this review, we discuss (i) the basic knowledge and molecular signaling relevant to hair regeneration and (ii) advanced technology medical treatments for hair loss (stem cells, HFCs, growth factor, EVs, gene therapy, and tissue engineers).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.